<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>The Saturday Evening Post &#187; male</title>
	<atom:link href="http://www.saturdayeveningpost.com/topics/male/feed" rel="self" type="application/rss+xml" />
	<link>http://www.saturdayeveningpost.com</link>
	<description>Home of The Saturday Evening Post</description>
	<lastBuildDate>Tue, 21 May 2013 20:09:20 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.5</generator>
		<item>
		<title>New Cancer Test Predicts Risk</title>
		<link>http://www.saturdayeveningpost.com/2008/12/19/health-and-family/medical-update/cancer-test-predicts-risk.html?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=cancer-test-predicts-risk</link>
		<comments>http://www.saturdayeveningpost.com/2008/12/19/health-and-family/medical-update/cancer-test-predicts-risk.html#comments</comments>
		<pubDate>Fri, 19 Dec 2008 15:36:35 +0000</pubDate>
		<dc:creator>Wendy Braun</dc:creator>
				<category><![CDATA[Medical Update]]></category>
		<category><![CDATA[clinical testing]]></category>
		<category><![CDATA[Life and Wellness]]></category>
		<category><![CDATA[male]]></category>
		<category><![CDATA[prostate cancer]]></category>

		<guid isPermaLink="false">http://72.3.135.59/wordpress/?p=1547</guid>
		<description><![CDATA[<p>Aureon Laboratories has introduced a first-of-its-kind test that uses biopsy tissue to predict the progression of prostate cancer and likelihood of its recurrence. The Prostate Px+ measures the clinical, anatomical, and molecular features present in men who are newly diagnosed with the disease, allowing for more informed and personalized treatment planning. For more information about [...]</p><p><a href="http://www.saturdayeveningpost.com/2008/12/19/health-and-family/medical-update/cancer-test-predicts-risk.html">New Cancer Test Predicts Risk</a>

<a href="http://www.saturdayeveningpost.com">The Saturday Evening Post</a></p>]]></description>
				<content:encoded><![CDATA[<p>Aureon Laboratories has introduced a first-of-its-kind test that uses biopsy tissue to predict the progression of prostate cancer and likelihood of its recurrence. The Prostate Px+ measures the clinical, anatomical, and molecular features present in men who are newly diagnosed with the disease, allowing for more informed and personalized treatment planning.</p>
<p>For more information about research on prostate cancer, go to <a href="http://capcure.org">capcure.org.</a></p>
<p>For more information about the new test, visit <a href="http://aureon.com">aureon.com</a></p>
<p><a href="http://www.saturdayeveningpost.com/2008/12/19/health-and-family/medical-update/cancer-test-predicts-risk.html">New Cancer Test Predicts Risk</a>

<a href="http://www.saturdayeveningpost.com">The Saturday Evening Post</a></p>]]></content:encoded>
			<wfw:commentRss>http://www.saturdayeveningpost.com/2008/12/19/health-and-family/medical-update/cancer-test-predicts-risk.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
